USPTO serial 79381593
CU BO CURCUMIN BOSWELLIA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 16, 2025
- Examiner
- VOHRA, SANJEEV KUMAR
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with CU BO CURCUMIN BOSWELLIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Robert S. Broder
Robert S. Broder Collard & Roe, P.C.1077 Northern Blvd.Roslyn, NY 11576United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Active chemical ingredients for use in the manufacture of pharmaceuticals for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, dietary supplements and dietetic preparations, all containing curcumin and boswellia; Chemical preparations for the manufacture of pharmaceuticals, dietary supplements and dietetic preparations, for treating of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome, all containing curcumin and boswellia; Chemical additives for use in the manufacture of food, all containing curcumin and boswellia. | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of gastrointestinal diseases, abdominal bloating, cardiovascular system diseases, gastroenteric system diseases, respiratory system diseases, immune and endocrine system diseases, chronic inflammatory diseases, skin diseases, urinary tract diseases, musculoskeletal disorders, metabolic diseases, ocular diseases, peripheral nervous disorders, ageing disorders, liver diseases, chronic fatigue syndrome diseases, all containing curcumin and boswellia; dietary supplements and dietetic preparations, all containing curcumin and boswellia; Plant and herb extracts, other than essential oils, for medicinal purposes, all containing curcumin and boswellia. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by INDENA S.p.A
- Other trademarks owned by INDENA S.p.A
- Other trademarks owned by INDENA S.p.A
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named CU BO CURCUMIN BOSWELLIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 16, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 27, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 27, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 16, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 16, 2025 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 16, 2025 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 29, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 29, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 23, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 24, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 30, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 30, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 15, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 15, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 12, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 25, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 30, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2024 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| May 16, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 15, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 26, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |